抗原
多发性骨髓瘤
基因
基因表达
生物
癌症研究
肿瘤细胞
免疫学
分子生物学
病毒学
遗传学
作者
Walter MT Braga,Bruna Rodrigues da Silva,Veruska L. Fook Alves,Adriana Bruscato Bortoluzo,Djordje Atanackovic,Gisele W. B. Colleoni
出处
期刊:Immunotherapy
[Future Medicine]
日期:2014-05-01
卷期号:6 (5): 569-575
被引量:1
摘要
Aim: The present study aimed at correlating the expression of cancer/testis antigens (CTAs) with the expression of genes related to tumor‐infiltrating T cells. Materials & methods: MAGE‐C1/CT‐7, MAGEA3/6, NY‐ESO‐1, LAGE‐1 and GAGE expression were evaluated in 46 bone marrow multiple myeloma (MM) aspirates by RT‐PCR. Expression of FOXP3/CTLA4 and RORyt, as markers for Tregs and Th17 cells, respectively, was investigated by quantitative PCR. Results: MAGEC1/CT7 was expressed in 66% of MM samples. We did not find correlation between the presence of single CTA and expression of CTLA4 or RORyt neither expression of CD4+ T‐cell markers and the number of CTA simultaneously expressed in the tumor. However, we did observe a correlation between the percentage of plasma cells and the number of CTAs expressed in the patients' bone marrow. Conclusion: Although CTAs and immunomodulatory CD4+ T cells represent potential targets for immunotherapy in MM, we did not find association among expression of such genes in MM.
科研通智能强力驱动
Strongly Powered by AbleSci AI